Ruth Helfgott

586 total citations
7 papers, 68 citations indexed

About

Ruth Helfgott is a scholar working on Cancer Research, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Ruth Helfgott has authored 7 papers receiving a total of 68 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cancer Research, 4 papers in Pathology and Forensic Medicine and 3 papers in Surgery. Recurrent topics in Ruth Helfgott's work include Breast Cancer Treatment Studies (6 papers), Breast Lesions and Carcinomas (4 papers) and Breast Implant and Reconstruction (3 papers). Ruth Helfgott is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Breast Lesions and Carcinomas (4 papers) and Breast Implant and Reconstruction (3 papers). Ruth Helfgott collaborates with scholars based in Austria, Switzerland and United States. Ruth Helfgott's co-authors include Florian Fitzal, Farid Moinfar, Daniela Kauer-Dorner, Guenther G. Steger, Michael Bolliger, Zsuzsanna Bagó-Horváth, C. Gruber, Martina Mittlböck, Kerstin Wimmer and Michael Knauer and has published in prestigious journals such as British Journal of Cancer, Annals of Surgical Oncology and Breast Cancer Research and Treatment.

In The Last Decade

Ruth Helfgott

7 papers receiving 67 citations

Peers

Ruth Helfgott

CR

ONCOL

PFM

SURGE

PRM

Erica Piccoli Italy

Tom van den Bosch Netherlands

Simone Di Maria Grimaldi Italy

Archana Balan United States

Krysta Chaldekas United States

Alexander Andreev-Drakhlin United States

Anne Sophie V M van den Heerik Netherlands

Agostinho Pinto Gouvêa Brazil

Alex Northrop United Kingdom

Francesca Gussago Italy

Erica Piccoli Italy

Ruth Helfgott

52 ×1.3

CR

46 ×1.8

ONCOL

21 ×0.9

PFM

28 ×1.3

SURGE

9 ×0.5

PRM

Citations per year, relative to Ruth Helfgott Ruth Helfgott (= 1×) peers Erica Piccoli

Countries citing papers authored by Ruth Helfgott

Since Specialization

Citations

This map shows the geographic impact of Ruth Helfgott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Helfgott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Helfgott more than expected).

Fields of papers citing papers by Ruth Helfgott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Helfgott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Helfgott. The network helps show where Ruth Helfgott may publish in the future.

Co-authorship network of co-authors of Ruth Helfgott

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Helfgott. A scholar is included among the top collaborators of Ruth Helfgott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Helfgott. Ruth Helfgott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Wimmer, Kerstin, Dominik Hlauschek, Marija Balić, et al.. (2024). Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?. Breast Cancer Research and Treatment. 205(2). 227–239. 1 indexed citations

2.

Steger, Guenther G., Daniel Egle, Rupert Bartsch, et al.. (2020). Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2− advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT. The Breast. 50. 64–70. 13 indexed citations

3.

Jahn, Stephan, Oleksiy Tsybrovskyy, Ruth Helfgott, et al.. (2020). Clinically high-risk breast cancer displays markedly discordant molecular risk predictions between the MammaPrint and EndoPredict tests. British Journal of Cancer. 122(12). 1744–1746. 11 indexed citations

4.

Helfgott, Ruth, Andreas Petzer, Hans Geinitz, et al.. (2020). Impact of contemporary therapy- concepts on surgical morbidity in breast cancer patients: A retrospective single center analysis of 829 patients. European Journal of Surgical Oncology. 46(8). 1477–1483. 2 indexed citations

5.

Wimmer, Kerstin, Michael Bolliger, Zsuzsanna Bagó-Horváth, et al.. (2019). Impact of Surgical Margins in Breast Cancer After Preoperative Systemic Chemotherapy on Local Recurrence and Survival. Annals of Surgical Oncology. 27(5). 1700–1707. 26 indexed citations

6.

Hammer, J., Hans Geinitz, Carsten Nieder, et al.. (2018). Risk Factors for Local Relapse and Inferior Disease-free Survival After Breast-conserving Management of Breast Cancer: Recursive Partitioning Analysis of 2161 Patients. Clinical Breast Cancer. 19(1). 58–62. 7 indexed citations

7.

Helfgott, Ruth, Martina Mittlböck, Farid Moinfar, et al.. (2018). The influence of breast cancer subtypes on axillary ultrasound accuracy: A retrospective single center analysis of 583 women. European Journal of Surgical Oncology. 45(4). 538–543. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact